Panretin Topical Gel 0.1pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Panretin: Topical gel (0.1%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

ALITRETINOIN (a li TRE ti noyn) is a naturally occurring form of vitamin A. It is used on the skin to treat Kaposi's sarcoma lesions. This gel does not treat other forms of Kaposi's sarcoma or prevent new skin lesions.

In-Depth Information
Select a Medication

Panretin 0.1% Topical Gel

NDC: 628560601
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved





Sometimes used for but not FDA approved for the following conditions:
Kaposi's Sarcoma

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Panretin 0.1% Topical Gel

Reported Side Effects for Panretin 0.1% Topical Gel

Swelling Incidence:
3.0-8.0%*
Severity: MODERATE
Onset: DELAYED
Exfoliative Dermatitis Incidence:
3.0-9.0%*
Severity: SEVERE
Onset: DELAYED
Paresthesias Incidence:
3.0-22.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
8.0-11.0%*
Severity: MILD
Onset: RAPID
Skin Rash Incidence:
25.0-77.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Panretin

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5